Traditional growth experimentation relies on rapid conversion cycles, large samples, and content without emotional weight. None of those assumptions apply in FemTech. We create a testing program that delivers genuine, ethical, statistically sound answers within those limitations.
The Challenge
Sample sizes within specific FemTech niches are too limited for conventional statistical significance thresholds
Many FemTech categories – specific fertility conditions, rare reproductive health issues, niche menopause segments – serve a genuinely smaller addressable population than a mainstream consumer app. Standard experimentation frameworks built around reaching statistical significance in days or weeks assume traffic volumes that some FemTech products simply do not have, which means a growth team following a generic testing playbook either runs tests too short to trust or waits so long that the business loses patience with experimentation entirely.
Certain tactics that increase conversion in other categories are unethical to test here
Urgency and scarcity tactics, aggressive exit-intent popups, and manipulative dark patterns can lift short-term conversion in most e-commerce categories. Applied to someone researching a fertility treatment, a pregnancy loss support product, or a menopause symptom, those same tactics exploit a moment of real vulnerability. A growth experimentation program that treats 'does it lift the metric' as the only test criterion will eventually greenlight something that should never have shipped, regardless of what the data says.
Long decision cycles cause standard test-duration guidelines to generate false negatives
A test that runs for the standard one-to-two-week cycle used in most growth experimentation programs will often show no significant effect on a FemTech product simply because the buyer has not finished their multi-week or multi-month decision process yet, not because the change genuinely had no effect. Killing tests on a standard timeline in this category throws away real signal before it has had time to appear.
Aggregate results obscure segment-level effects across a genuinely non-uniform audience
A messaging change might perform very differently for someone in active fertility treatment versus someone in early research, or for a first-time visitor versus someone returning after a life event. Standard A/B testing that reports only an aggregate lift or loss can hide a change that helped one segment and hurt another, and shipping based on the aggregate number alone can quietly damage the experience for a subset of users the test never surfaced.
How We Support You
We begin by sizing the experimentation program around your real traffic and sample size, applying sequential testing methods and pre-registered minimum detectable effects that accurately reflect what your traffic can support, instead of launching tests that are underpowered from the outset.
We incorporate an ethical review layer directly into the test intake process: before any test involving urgency, scarcity, or emotionally sensitive content goes live, it is assessed against one straightforward standard – would this be defensible if a user at a vulnerable moment saw exactly what we're testing and understood it was a test. This is not a bureaucratic hurdle; it is a quick check that identifies tests that should never have been suggested.
We adapt test-duration guidelines to your real decision cycle rather than relying on a generic one-to-two-week default, using leading indicators identified during the research phase – content engagement depth, return visits – to provide an earlier read on tests requiring a longer window to reveal their actual impact on final conversion.
We make segment-level analysis a default part of every test, rather than a follow-up inquiry after unclear aggregate results, ensuring that a change benefiting one segment while harming another is identified before broad release, not after users have already felt the effects.
What sets this apart from a conventional growth experimentation program: most programs prioritize speed and view ethical and statistical rigor as obstacles to velocity. In FemTech, rigor prevents experimentation from generating results that are statistically inaccurate or ethically indefensible, and either failure costs more than any velocity gained.
What we deliver
- Right-sized experimentation framework using sequential testing methods matched to actual traffic and sample size
- Ethical review layer built into test intake for urgency, scarcity, and emotionally sensitive content
- Extended test duration guidelines matched to real multi-week or multi-month decision cycles
- Segment-level analysis built into every test by default, not as follow-up investigation
- Documented experimentation playbook and test-intake process your team owns going forward
The growth experimentation programs that succeed in FemTech are not the quickest; they are the ones that embed ethical review and statistical honesty into the process. A lift achieved by exploiting someone's worst week is not a win, and a test ended prematurely because it followed a generic timeline is not a loss; it is a false negative.
Our Methodology
We deliver growth experimentation through a 90-day sprint. Days 1 to 25 assess your current testing program: examining previous test results for statistical validity based on actual sample sizes, along with any tests that may have deployed tactics worth revisiting for ethical reasons.
Days 26 to 65 establish the new framework: sequential testing methods calibrated to your real traffic, an ethical review layer for test intake, longer duration guidelines aligned with your decision cycle, and segment-level analysis included in standard reporting.
Days 66 to 90 complete a live testing cycle with the new framework and transfer a documented playbook your team can operate independently. What separates this from a typical growth experimentation engagement: most engagements prioritize testing velocity. We prioritize tests that are statistically sound and ethically defensible, because in a category where users are often vulnerable, a quick wrong answer is worse than a slower correct one.
Our Working Approach
The initial 30 days focus heavily on auditing: evaluating prior experimentation results against real traffic and sample sizes to identify conclusions that may have been statistically unreliable, and assessing tests involving urgency or emotionally sensitive content against the ethical standard we're introducing. By day 30, you know precisely what needs fixing in the current program.
Days 30 to 65 develop the new framework step by step: sequential testing methodology, the ethical review process, longer duration guidelines, and reporting for segment-level analysis, all validated through a small number of live experiments before becoming the standard process.
Days 65 to 90 complete a full live testing cycle within the new framework and finalize a documented playbook. Staffing includes a growth experimentation lead and data analyst collaborating with your product and engineering teams; you provide access to existing experimentation tools, historical testing data, and product/engineering resources for implementation. Engagements usually last 3-4 months, with continued experimentation support scoped separately.
- Statistically valid test conclusions matched to actual sample size and traffic
- Ethical review completion rate for tests involving sensitive content or urgency tactics
- Segment-level effects caught before broad rollout, avoiding hidden harm to a subset of users
If your femtech company needs growth experimentation leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What is the cost of growth experimentation for a FemTech company?
Most engagements cost roughly the same as a senior growth experimentation hire across a 3-4 month sprint. Pricing is driven mainly by how much of your current testing infrastructure can be expanded, compared with what must be rebuilt to support sequential testing methods and segment-level reporting.
How soon will we see results from a growth experimentation engagement?
The framework and ethical review process can be up and running within the first 30 days. Complete test cycles that honor your real decision timeline require more time than a standard two-week test, commonly 45-90 days depending on the typical decision cycle in your category. That is intentional: a quicker but false result is not truly a quicker answer.
How will the experimentation team collaborate with our current product and engineering staff?
We collaborate directly with your product, engineering, and data teams to integrate the new framework into your current experimentation tooling instead of creating a separate system. Product teams play an especially active role in the ethical review layer because they typically have the clearest understanding of which tests intersect with genuinely vulnerable moments.
How does Winston Francois differ from a standard growth experimentation consultancy?
Most growth experimentation consultancies prioritize test velocity through generic statistical thresholds and duration guidelines. We create an experimentation program calibrated to your real traffic and decision cycle, including an ethical review layer that most growth programs omit entirely, because velocity resulting in false or harmful outcomes is not genuine progress.
How do you measure ROI for a growth experimentation engagement?
We measure the proportion of statistically valid conclusions under the new framework compared with the old one, segment-level impacts identified before broad release, and the ethical review completion rate for sensitive tests. The true ROI comes from shipping fewer false positives and exposing real users to fewer harmful tests, protecting conversion and trust over the long term.
Which type of FemTech company is best suited to growth experimentation work?
This work suits companies that already have a testing program and sufficient traffic to conduct a meaningful experimentation cycle, typically from Series A through growth stage. It is especially well suited to companies that have run tests they believe were underpowered or ethically questionable, or teams frustrated by standard test-duration guidelines repeatedly yielding inconclusive results.
